Henlius Partners With Getz To Commercialize Adalimumab Biosimilar

Companies Plan To Cover 11 Emerging Markets In Asia, Africa And Europe

 
• By Akriti Seth
  
Emerging Market
Shanghai Henlius Biotech and Pakistan based Getz Pharma partner to commercialize adalimumab biosimilar in emerging markets • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products